3de-Gramont A, Figer A, Seymour M, et al. Leueovorin and fluorouraeil with or without oxaliplatin as first-line treatment in advanced eoloreetal cancer[ J ]. J Clin Oneol, 2000,18:2938-2947. 被引量：1
4Extra J,Espie M,Calvo F,et al. Phase I study of oxaliplatin in patients with advanced cancer [ J ]. Cancer Chemother Pharmacol, 1990,25 : 299 -303. 被引量：1
5Extra JM, Marty M, Brienza S, et al. Pharmacokinetics and safety profile of oxaliplatin [ J ]. Semin Oncol, 1998,25 : 13-22. 被引量：1
6Andre T, Bensmaine MA, Louver C, et al. Muhicenter phase Ⅱ study of bimonthly high-dose leueovorin,fluorouracil infusion,and oxaliplatin for metastatic colorectal cancer resistant to the same leucovorin and fluorouracil regimen [ J ]. J Clin Oncol, 1999,17:3560-3568. 被引量：1
7Murrie V, Gill J,Windebank A. Neurotoxic potential of platin compounds: role of cell cycle element [ J ]. Soc Neurosei,1998,24 : 1794. 被引量：1
8刘新春等主编..实用抗肿瘤药物治疗学[M].北京:人民卫生出版社,2002:1125.
二级参考文献6
1De Gramont A, Krulik M, Cady J, et al. High-dose folinic acid and 5-fluorouracil bolus and continuous infusion in advanced colorectal cancer.Eur J Cancer Clin Oncol, 1988, 24:1499-1503. 被引量：1
2Ajani JA. Current status of therapy for advanced gastric carcinoma.Oncology, 1998, 12:99-102. 被引量：1
3Raymond E, Charley SG, Taamma A, et al. Oxaliplatin: a review of preclinical and clinical studies. Ann Oncol, 1998, 9:1053-1071. 被引量：1
4De Gramont A, Figer A, Seymonr M, et al. Leucovorin and fluorouracil with or without oxaliplatin as frist-line treatment in advanced colorectal cancer. J Clin Oncol, 2000,18:2938-2947. 被引量：1
5De Gramont A, Bosset JF, Milan C, et al. Randomized trial comparing monthly low-dose leucovorin and fluorouracil bolus with bimonthly highdose leucovorin and fluorouracil bolus plus continuous infusion for advanced colorectal cancer : a French intergroup study. J Clin Oncol,1997, 15:808-815. 被引量：1
